Abstract
Cell-mediated immunity is often impaired in cancer. This may be partly due to increased amounts of prostaglandin E2 (PGE2) and histamine in the blood of cancer patients, since PGE2 and histamine possess inhibitory effects on cellular immunity. These effects are mediated by cyclic AMP (cAMP), which is increased in leukocytes by PGE2 through EP2 and by histamine through H2 receptors and also by epinephrine through β2-adrenergic receptors. Increased cAMP activates protein kinase A, which inhibits the formation of interleukin 2 (IL-2) in T cells. The formation of interferon y is concomitantly decreased, and cellular immunity is attenuated. In monocyte/macrophages the formation of IL-1β, IL-12 and tumor necrosis factor a is decreased by cAMP or through the increased formation of IL-10, which is up-regulated by cAMP. This attenuates cellular immunity. In monocytes histamine may decrease the formation of oxygen intermediates, which can induce apoptosis of natural killer cells and thus inhibit immunity. The superoxide anion is a potent inducer of the cyclooxygenase-2 enzyme, which is upregulated in colorectal cancer. Cyclooxygenase-2 catalyzes the formation of PGE2, e. g. in cancer cells. Thus the inhibition of cellular immunity in cancer may be at least partly mediated by cAMP and oxygen intermediates. This may offer new options for cancer immunotherapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abramson SL, Gallin JI (1990) IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 144: 625
Anastassiou ED, Paliogianni F, Balow JP, Yamada H, Boumpas DT (1992) Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J Immunol 148: 2845
Angel P, Karin M (1991) The role of Jun, Fos and AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129
Arend WP, Gordon OF, Wood WM, Janson RW, Joskin FG, Jameel S (1989) IL-1β production in cultured human monocytes is regulated at multiple levels. J Immunol 143: 118
Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M, Feramisco J, Montminy M (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370: 226
Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G (1994) Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol 156: 480
Barinaga M (1995) Two major signaling pathways meet at MAP-kinase. Science 269: 1673
Bast A, Savenije-Chapel EM, Kroes BH (1984) Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers. Xenobiotica 14: 399
Bauman GP, Bartik MM, Brooks WH, Roszman TL (1994) Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the β-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell Immunol 158: 182
Bennet A, Civier A, Hensby CN, Melhuish PB, Stamford IF (1987) Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut 28: 315
Beutler B, Van Huffel C (1994) Unraveling function in the TNF ligand and receptor families. Science 264: 667
Bravo R, Nueberg M, Burckhardt J, Almendral J, Wallich R, Müller R (1987) Involvement of common and cell type-specific pathways in c-fos gene control: Stable induction by cAMP in macrophages. Cell 48: 251
Brodde O-E, Engel G, Hoyer D, Bock KD, Weber F (1981) The β-adrenergic receptor in human lymphocytes: subclassification by the use of a new radioligand (+)-125iodocyanopindolol. Life Sci 29: 2189
Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G (1991) Induction of interferon y production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173: 869
Chiu R, Angel P, Karin M (1989) Jun-B differs in its biological properties from, and is a negative regulator of, cJun. Cell 59: 979
Coleman RA, Smith WL, Narumiya S (1994) VIII International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacal Rev 46: 205
Cook SJ, McCormick F (1993) Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069
D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178: 1041
De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209
Di Giovine F, Duff GW (1990) lnterleukin 1: the first interleukin. Immunol Today 11: 13
Dohlsten M, Sjögren HO, Carlsson R (1987) Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-γ production. Cell Immunol 109: 65
Dohlsten M, Hedlund G, Fischer H, Sjögren HO, Carlsson R (1989) Proliferation of human CD4+45R+ and CD+45R- T helper cells is promoted by both IL-2 and IL-4 while interferon-gamma production is restricted to IL-2 activated CD4+45R- T cells. Immunol Lett 20: 29
Donnelly RP, Fenton MJ, Kaufmann JD, Gerrard TL (1991) IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4. J Immunol 146: 3431
Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183
Emorine LJ, Marullo S, Delavier-Klutchko C, Kaveri SV, Durieu-Trautmann O, Strosberg AD (1987) Structure of the gene for human β2-adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci USA 84: 6995
Engelhard VH (1994) How cells process antigens. Sci Am 271: 44
Essner R, Rhoades K, McBride WH, Morton DL, Economou JS (1989) IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 142: 3857
Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest 95: 1669
Fiorentino OF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815
Fischer H, Hedlund G, Kalland T, Sjögren HO, Dohlsten M (1990) Independent regulation of IFN-γ and tumor necrosis factor by IL-1 in human T helper cells. J Immunol 145: 3767
Freeman BA, Crapo JD (1982) Biology of disease: free radicals and tissue injury. Lab Invest 47: 412
Galbraith RA, Michnovicz JJ (1989) The effects of cimetidine on the oxidative metabolism of estradiol. N Engl J Med 321: 269
Gantz I, Munzert G, Tashiro T, Schäffer M, Wang L, DelValle J, Yamada T (1991) Molecular cloning of human histamine H2 receptor. Biochem Biophys Res Commun 178: 1386
Garcia-Penarrubia P, Bankhurst AD, Koster FT (1989) Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer antibacterial activity. J Exp Med 170: 601
Gastl G, Niederwieser D, Marth C, Huber H, Egg D, Schuler G, Margreiter R, Braunsteiner H, Huber C (1984) Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states. Blood 64: 288
Goodman Gilman A, Rail TW, Nies AS, Taylor P ( 1990) Goodman and Gilman's The pharmacological basis of therapeutics, 8th edn. Pergamon, New York
Goto T, Herberman RB, Maluish A, Strong OM (1983) Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. J Immunol 130: 1350
Halliwell B, Gutteridge JMC (1991) Free radicals in biology and medicine, 2nd edn. Clarendon, Oxford
Hansson M, Asea A, Ersson U, Hermodsson S, Hellstrand K (1996) Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J Immunol 156: 42
Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli OS, Hamilton JA (1989) Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 86: 3803
Hart PH, Whitty GA, Piccoli OS, Hamilton JA (1989) Control by IFN-γ and PGE2 of TNFα and IL-1 production by human monocytes. Immunology 66: 376
Hellstrand K, Hermodsson S ( 1987) Differential effects of histamine receptor antagonists on human natural killer cell activity. Int Arch Allergy Appl Immunol 84: 247
Hellstrand K, Hermodsson S (1989) An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int Arch Allergy Appl Immunol 89: 334
Hellstrand K, Hermodsson S (1990) A cell-to-cell mediated interaction involving monocytes and non-T/CD16+ natural killer (NK) cells is required for histamine H2-receptor-mediated NK-cell activation. Scand J Immunol 31: 631
Hellstrand K, Asea A, Hermodsson S (1990) Role of histamine in natural killer cell-mediated resistance against tumor cells. J lmmunol 145: 4365
Hellstrand K, Asea A, Dahlgren C, Hermodsson S (1994) Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. J Immunol 153: 4940
Honda A, Sugimoto Y, Namba T, Watabe A, Irie A, Negishi M, Narumiya S, Ichikawa A (1993) Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J Biol Chem 268: 7759
Hotermans G, Bury T, Radermecker MF (1991) Effect of histamine on tumor necrosis factor production by human monocytes. Int J Allergy Appl Immunol 95: 278
Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O (1994) Signaling by the cytokine receptor superfamily; JAKs and STATs. Trends Biochem Sci 19: 222
Israel A (1994) NF-AT comes under control. Nature 369: 443
Jain J, McCaffrey PG, Valge-Archer VE, Rao A (1992) Nuclear factor of activated T cells contains Fos and Jun. Nature 356: 801
Jones DA, Carlton DP, Mcintyre TM, Zimmerman GA, Prescott SM (1993) Molecular cloning of human prostaglandin endoperoxide synthase Type II and demonstration of expression in response to cytokines. J Biol Chem 268: 9049
Kammer GM (1988) The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 9: 222
Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556
Katz P, Zaytoun AM, Fauci AS (1982) Mechanisms of human cell-mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides. J Immunol 129: 287
Khan MM, Sansoni P, Engleman EG, Melmon KL (1985) Pharmacologic effects of autacoids on subsets of T cells. J Clin Invest 75: 1578
Khan MM, Sansoni P, Silverman ED, Engleman EG, Melmon KL (1986) Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochem Pharmacol 35: 1137
Kishimoto T, Taga T, Akira S (1994) Cytokine signal transduction. Cell 76: 253
Knodell RG, Browne DG, Gwozdz GP, Brian WR, Guengerich FP (1991) Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 101: 1680
Kobayaski M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 170: 827
Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ (1987) eDNA for the human β2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 84: 46
Kobilka BK, Matsui H, Kobilka TS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ, Regan JW (1987) Cloning, sequencing, and expression of the gene coding for the human platelet α2-adrenergic receptor. Science 238: 650
Krause DS, Deutsch C (1991) Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. J Immunol 146: 2285
Kubota Y, Sunouchi K, Ono M, Sawaka T, Muto T (1992) Local immunity and metastasis of colorectal carcinoma. Dis Colon Rectum 35: 645
Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D (1988) Prostaglandin Ez regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263: 5380
Kärre K, Hansson M, Kiessling R (1991) Multiple interactions at the natural killer workshop. Immunol Today 12: 343
Last-Barney K, Homon CA, Faanes RB, Merluzzi VJ (1988) Synergistic and overlapping activities of tumor necrosis factor-α and IL-1. J Immunol 141: 527
Lehn M, Weiser WY, Engelhom S, Gillis S, Remold HG (1989) IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-γ. J Immunol 143: 3020
Liou H-C, Baltimore D (1993) Regulation of the NK-kB/rel transcription factor and IkB inhibitor system. Curr Opin Cell Biol 5: 477
Marx J (1993) Forging a path to the nucleus. Science 260: 1588
Marx J (1993) Two major signal pathways linked. Science 262: 988
Mary D, Aussel C, Ferrua B, Fehlmann M (1987) Regulation of interleukin2 synthesis by cAMP in human T cells. J Immunol 139: 1179
McCaffrey PG, Luo C, Kerppola TK, Jain J, Badalian TM, Ho AM, Burgeon E, Lane WS, Lambert JN, Curran T, Verdine GL, Rao A, Hogan PG (1993) Isolation of cyclosporin-sensitive T cell transcription factor NFATp. Science 262: 750
McLemore TL, Hubbard WC, Litterst CL, Liu MC, Miller S, McMahon NA, Eggleston JC, Boyd MR (1988) Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. Cancer Res 48: 3140
Meade EA, Smith WL, DeWitt DL (1993) Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs. J Biol Chem 268: 6610
Merluzzi VJ, Faanes RB, Czajkowski M, Last-Barney K, Harrison PC, Kahn J, Rothlein R (1987) Membrane-associated interleukin 1 activity on human U937 tumor cells: stimulation of PGEz production by human chondrosarcoma cells. J Immunol 139: 166
Mertz PM, DeWitt DL, Stetler-Stevenson WG, Wahl LM (1994) Interleukin 10 suppression of monocyte prostaglandin H synthase-2. J Biol Chem 269: 21322
Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR (1993) Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90: 11 693
Moriarty CM, Stucky JL, Hamburger KW, Patil KD, Foley JF, Koefoot RR (1988) Blood histamine and solid malignant tumors. J Cancer Res Clin Oncol 114: 588
Narisawa T, Kusaka H, Yamazaki Y, Takahashi M, Koyama H, Koyama K, Fukaura Y, Wakizaka A (1990) Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer. Dis Colon Rectum 33: 840
Newton RC (1985) Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity. Immunol 56: 441
Niiro H, Otsuka T, Tanabe T, Hara S, Kuga S, Nemoto Y, Tanaka Y, Nakashima H, Kitajima S, Abe M, Niho Y (1995) Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood 85: 3736
Northrop JP, Ullman KS, Crabtree GR (1993) Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J Biol Chem 268: 2917
Northrop JP, Ho SN, Chen L, Thomas DJ, Timmerman LA, Nolan GP, Admon A, Crabtree GR (1994) NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369: 497
O'Banion MK, Winn VD, Young DA (1992) eDNA cloning and functional activity of glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 89: 4888
Ogasawara H, Fujitani T, Drzewiecki G, Middleton E (1986) The role of hydrogen peroxide in basophil histamine release and the effect of selected flavonoids. J Allergy Clin Immunol 78: 321
Ozaki M, Morii H, Qvist R, Watanabe Y (1994) Interleukin-1β induces cytosolic phospholipase A2 gene in rat C6 glioma cell line. Biochem Biophys Res Commun 205: 12
Paul WE, Seder RA (1994) Lymphocyte responses and cytokines. Cell 76: 241
Pelkonen O, Breimer DO (1994) Role of environmental factors in the pharmacokinetics of drugs: considerations with respect to animal models, P-450 enzymes, and probe drugs: In: Welling PG, Balant LP (eds) Handbook of experimental pharmacology, vol 110. Pharmacokinetics of drugs. Springer, Berlin Heidelberg New York, pp 289
Pene J, Rousset F, Briere F, Chretien I, Paliard X, Banchereau J, Spits H, De Vries JE (1988) IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-γ. J Immunol 141: 1218
Phipps RP, Stein SH, Roper RL (1991) A new view of prostaglandin E regulation of the immune response. Immunol Today 12: 349
Powell JR, Donn KH (1984) Histamine Hz-antagonist drug interactions in perspective: mechanistic concepts and clinical implications. Am J Med 77 [Suppl 5B]: 57
Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min H-Y, Lin L (1992) IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 148: 808
Ramstedt U, Ng J, Wigzell H, Serhan CN, Samuelsson B (1985) Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects of intracellular cAMP and target cell binding. J Immunol 135: 3434
Riabowol KT, Fink JS, Gilman MZ, Walsh DA, Goodman RH, Feramisco JR (1988) The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMPresponsive enhancer elements. Nature 336: 83
Rigas B, Goldman IS, Levine L (1993) Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122: 518
Rincon M, Tugores A, Lopez-Rivas A, Silva A, Alonso M, De Landazuri MO, Lopez-Botet M (1988) Prostaglandin E2 and the increase of intracellular cAMP inhibits the expression of interleukin-2 receptors in human T cells. Eur J Immunol 18: 1791
Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD (1983) Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 61: 1132
Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785
Scott P (1993) IL-12: initiation cytokine for cell-mediated immunity. Science 26: 496
Severn A, Rapson NT, Hunter CA, Liew FY (1992) Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J Immunol 148: 3441
Smith KA (1990) Interleukin-2. Sci Am 262: 26
Smith WL, Marnett LJ (1991) Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta 1083: 1
Soiffer RJ, Robertson MJ, Murray C, Cochran K, Ritz J (1993) Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 82: 2790
Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL ( 1990) Stimulation of a-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 145: 1430
Spengler RN, Chensue SW, Giacherio DA, Blenk N, Kunkel SL (1994) Endogenous norepinephrine regulates tumor necrosis factor-α production from macrophages in vitro. J Immunol 152: 3024
Strassmann G, Patil-Koota V, Finkelman F, Fong M, Kambayashi T (1994) Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med 180: 2365
Strieter RM, Remick DG, Ham JM, Colletti LM, Lynch JP, Kunkel SL (1990) Tumor necrosis factor-alpha gene expression in human blood. J Leukoc Biol 47: 366
Subramanian N, Bray MA (1987) Interleukin 1 releases histamine from human basophils and mast cells in vitro. J Immunol 138: 271
Theoharides TC, Kops SR, Bondy PK, Askenase PW (1985) Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem Pharmacal 34: 1389
Tønnesen H, Knigge U, Bülow S, Damm P, Fischerman K, Hesselfeldt P, Hjortrup A, Pedersen IK, Pedersen VM, Siemssen OJ, Svendsen LB, Christiansen PM (1988) Effect of cimetidine on survival after gastric cancer. Lancet 2: 990
Trinchieri G (1993) Interleukin-12 and its role in the generation of Thl cells. Immunol Today 14: 335
Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, Aste-Amezaga M, Kubin M, Valiante NM, Chehimi J (1992) Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res 4: 355
Trinchieri G, Scott P (1994) The role of interleukin 12 in the immune response, disease and therapy. Immunol Today 15: 460
Uotila P (1993) Inhibition of prostaglandin Ez formation and histamine action in cancer immunotherapy. Cancer Immunol Immunother 37: 251
Uotila P, Vapaatalo H (1984) Synthesis, pathways and biological implications of eicosanoids. Ann Clin Res 16: 226
Van der Pouw Kraan TCTM, Boeije LCM, Smeenk RJT, Wijdenes J, Aarden LA (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181: 775
Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW (1993) Inhibition of the EGF-activated AMP kinase signaling pathway by adenosine 3’,5’ -monophosphate. Science 262: 1065
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uotila, P. The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol Immunother 43, 1–9 (1996). https://doi.org/10.1007/BF03354243
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03354243